|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2002-9-16
|
|
pubmed:abstractText |
Positron emission tomography (PET) determines therapy-induced changes in tumour glucose utilization. Experimental data indicate that cholecystokinin (CCK) stimulates pancreatic cancer growth. In this study in patients with advanced pancreatic cancer, we evaluated the use of fluorodeoxyglucose (FDG) PET compared with magnetic resonance imaging (MRI) in monitoring hormonal therapy using a highly selective, non-peptide CCK receptor antagonist (SR 27897B).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0036-5521
|
|
pubmed:author |
pubmed-author:DeckerMM,
pubmed-author:EckelFF,
pubmed-author:FrankRR,
pubmed-author:HelmbergerHH,
pubmed-author:LerschCC,
pubmed-author:LippaMM,
pubmed-author:NeverveJJ,
pubmed-author:Schulte-FrohlindeEE,
pubmed-author:SchusdziarraVV,
pubmed-author:SchwaigerMM,
pubmed-author:WeberWW
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
972-7
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12229975-Adenocarcinoma,
pubmed-meshheading:12229975-Adult,
pubmed-meshheading:12229975-Aged,
pubmed-meshheading:12229975-Female,
pubmed-meshheading:12229975-Fluorodeoxyglucose F18,
pubmed-meshheading:12229975-Glucose,
pubmed-meshheading:12229975-Hormone Antagonists,
pubmed-meshheading:12229975-Humans,
pubmed-meshheading:12229975-Indoleacetic Acids,
pubmed-meshheading:12229975-Magnetic Resonance Imaging,
pubmed-meshheading:12229975-Male,
pubmed-meshheading:12229975-Middle Aged,
pubmed-meshheading:12229975-Pancreatic Neoplasms,
pubmed-meshheading:12229975-Radiopharmaceuticals,
pubmed-meshheading:12229975-Receptors, Cholecystokinin,
pubmed-meshheading:12229975-Thiazoles,
pubmed-meshheading:12229975-Tomography, Emission-Computed
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Monitoring of tumour glucose metabolism by PET in a phase I study evaluating hormonal therapy in advanced pancreatic cancer.
|
|
pubmed:affiliation |
Dept of Medicine II, Klinikum rechts der Isar, Technical University of Munich, Germany. florian.eckel@lrz.tum.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
